Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Hull

Showing results (41-50 of 123) with videos related to

Pageof 13
Sort By:
European Journal of Gastroenterology & Hepatology|December 9, 2010
Hepatitis C virus treatment rates and outcomes in HIV/hepatitis C virus co-infected individuals at an urban HIV clinicMelanie C M Murray, Rolando Barrios, Wendy Zhang, et al.
The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale|July 30, 2016
CIHR Canadian HIV Trials Network Coinfection and Concurrent Diseases Core Research Group: 2016 Updated Canadian HIV/Hepatitis C Adult Guidelines for Management and TreatmentMark Hull, Stephen Shafran, Alex Wong, et al.
Plos One|May 4, 2017
A prognostic model for development of significant liver fibrosis in HIV-hepatitis C co-infectionNasheed Moqueet, Cynthia Kanagaratham, M John Gill, et al.
AIDS Patient Care and Stds|May 17, 2023
Injectable Pre-Exposure Prophylaxis for HIV Prevention: Perspectives on the Benefits and Barriers from Gay, Bisexual, and Queer Men and Health System Stakeholders in Ontario, CanadaDaniel Grace, Mark Gaspar, Alex Wells, et al.
The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale|July 2, 2016
Successful Treatment of Hepatitis C with Simeprevir, Sofosbuvir, and Ribavirin in an HIV Coinfected Liver Transplant Patient with Advanced Chronic Kidney DiseaseAnna Maruyama, Trana Hussaini, Nilufar Partovi, et al.
AIDS Care|November 19, 2025
Impact of "absolute" versus "relative" HIV risk communication on pre-exposure prophylaxis interest in Canada: a randomized surveyMyo Minn Oo, Sawyer Karabelas-Pittman, Mark Hull, et al.
AIDS (London, England)|December 22, 2016
Rates and predictors of injury in a population-based cohort of people living with HIVHasina Samji, Wendy Zhang, Oghenowede Eyawo, et al.
Current HIV Research|September 7, 2013
Evaluation of treatment tolerability, satisfaction and laboratory parameters in HIV+ patients switching from ritonavir capsule to tablet formulationAndy Mtambo, Marianne Harris, Junine Toy, et al.
Journal of Clinical Immunology|August 16, 2017
Bialellic Mutations in Tetratricopeptide Repeat Domain 7A (TTC7A) Cause Common Variable Immunodeficiency-Like Phenotype with EnteropathyDylan Lawless, Anoop Mistry, Philip M Wood, et al.
CMAJ Open|June 27, 2023
Reasons for not using pre-exposure prophylaxis for HIV and strategies that may facilitate uptake in Ontario and British Columbia among gay, bisexual and other men who have sex with men: a cross-sectional surveyOscar Javier Pico-Espinosa, Mark Hull, Paul MacPherson, et al.
Pageof 13

Showing results (41-50 of 123) with videos related to

Sort By:
Pageof 13
European Journal of Gastroenterology & Hepatology|December 9, 2010
Hepatitis C virus treatment rates and outcomes in HIV/hepatitis C virus co-infected individuals at an urban HIV clinicMelanie C M Murray, Rolando Barrios, Wendy Zhang, et al.
The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale|July 30, 2016
CIHR Canadian HIV Trials Network Coinfection and Concurrent Diseases Core Research Group: 2016 Updated Canadian HIV/Hepatitis C Adult Guidelines for Management and TreatmentMark Hull, Stephen Shafran, Alex Wong, et al.
Plos One|May 4, 2017
A prognostic model for development of significant liver fibrosis in HIV-hepatitis C co-infectionNasheed Moqueet, Cynthia Kanagaratham, M John Gill, et al.
AIDS Patient Care and Stds|May 17, 2023
Injectable Pre-Exposure Prophylaxis for HIV Prevention: Perspectives on the Benefits and Barriers from Gay, Bisexual, and Queer Men and Health System Stakeholders in Ontario, CanadaDaniel Grace, Mark Gaspar, Alex Wells, et al.
The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale|July 2, 2016
Successful Treatment of Hepatitis C with Simeprevir, Sofosbuvir, and Ribavirin in an HIV Coinfected Liver Transplant Patient with Advanced Chronic Kidney DiseaseAnna Maruyama, Trana Hussaini, Nilufar Partovi, et al.
AIDS Care|November 19, 2025
Impact of "absolute" versus "relative" HIV risk communication on pre-exposure prophylaxis interest in Canada: a randomized surveyMyo Minn Oo, Sawyer Karabelas-Pittman, Mark Hull, et al.
AIDS (London, England)|December 22, 2016
Rates and predictors of injury in a population-based cohort of people living with HIVHasina Samji, Wendy Zhang, Oghenowede Eyawo, et al.
Current HIV Research|September 7, 2013
Evaluation of treatment tolerability, satisfaction and laboratory parameters in HIV+ patients switching from ritonavir capsule to tablet formulationAndy Mtambo, Marianne Harris, Junine Toy, et al.
Journal of Clinical Immunology|August 16, 2017
Bialellic Mutations in Tetratricopeptide Repeat Domain 7A (TTC7A) Cause Common Variable Immunodeficiency-Like Phenotype with EnteropathyDylan Lawless, Anoop Mistry, Philip M Wood, et al.
CMAJ Open|June 27, 2023
Reasons for not using pre-exposure prophylaxis for HIV and strategies that may facilitate uptake in Ontario and British Columbia among gay, bisexual and other men who have sex with men: a cross-sectional surveyOscar Javier Pico-Espinosa, Mark Hull, Paul MacPherson, et al.
Pageof 13